Shares of Myovant Sciences
MYOV,
+29.58%
soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.
PFE,
-0.72%
to jointly develop… [+1108 chars]
UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion – MarketWatch
